EXECUTIVE ENGAGEMENTS
POOL
4666
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
842
Interactions with Platform & by Email
PARTICIPANTS
142
Unique # Participated
VALIDATIONS
42
Responses Validated*
COMPANIES
41
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
405
PAGES
476
EDITION
18
PRICE
USD 5450
CODE
MCP-6755
*Engagement stats are ongoing and dynamic
Login to access data silos
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for High Throughput Screening (HTS) estimated at US$14.5 Billion in the year 2020, is projected to reach a revised size of US$22.7 Billion by 2027, growing at a CAGR of 6.6% over the analysis period 2020-2027. Consumables/Reagents, one of the segments analyzed in the report, is projected to record a 7.1% CAGR and reach US$13.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6.1% CAGR for the next 7-year period.
The High Throughput Screening (HTS) market in the U.S. is estimated at US$3.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.9 Billion by the year 2027 trailing a CAGR of 10.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.6% and 5.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.
In the global Software & Services segment, USA, Canada, Japan, China and Europe will drive the 5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.9 Billion in the year 2020 will reach a projected size of US$2.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.1 Billion by the year 2027, while Latin America will expand at a 6.6% CAGR through the analysis period.
SELECT PLAYERS
Agilent Technologies, Inc.; Aurora Biomed Inc.; Axxam SpA; BD Biosciences; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; BioTek Instruments Inc.; BMG LABTECH GmbH; Charles River Laboratories International Inc.; Corning Inc.; Danaher Corporation; Evotec AG; F. Hoffmann-La Roche Ltd.; Genedata AG; IntelliCyt® Corporation; Luminex Corporation; Molecular Devices Inc.; Pall ForteBio LLC; PerkinElmer Inc.; Sigma-Aldrich Corp.; Tecan Group Ltd.; Thermo Fischer Scientific Inc.
SEGMENTS
» Product Type (Consumables/Reagents, Instruments, Software & Services) » Technology (Cell-based Assay, Label-Free Technology, Other Technologies) » Application (Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment, Other Applications) » End-Use (Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO), Other End-Uses)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| High Throughput Screening (HTS): A Prelude |
| Recent Market Activity |
| HTS: The Mainstream Technology for Drug Discovery Programs |
| Unparalleled Advantages in Compound Screening Drives Wider Adoption |
| Key Benefits of HTS - An Overview |
| Soaring R&D Spending Creates Conducive Environment for HTS |
| Shift towards High Throughput Research Builds Momentum for HTS |
| Upward Trajectory in Med Tech Sector Generates Parallel Opportunities |
| Stable Economic Outlook to Keep Market Sentiment Intact in the Near Term |
| Developed Regions: Key Revenue Contributors |
| HTS Adoption Continues to Expand in Developing Regions |
| Key Factors Driving Demand for HTS in the Developing Regions |
| Competitive Scenario |
| Leading Players in the World HTS Market |
| M&A Activity |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Agilent Technologies, Inc. (USA) |
| Aurora Biomed, Inc. (Canada) |
| Axxam SpA (Italy) |
| BD Biosciences (USA) |
| Danaher Corporation (USA) |
| Beckman Coulter, Inc. (USA) |
| Molecular Devices Inc. (USA) |
| Pall ForteBio LLC (USA) |
| Bio-Rad Laboratories, Inc. (USA) |
| BioTek Instruments Inc. (USA) |
| BMG LABTECH GmbH (Germany) |
| Charles River Laboratories International, Inc. (USA) |
| Corning Inc. (USA) |
| DiscoveRx Corporation (USA) |
| Evotec AG (Germany) |
| F. Hoffmann-La Roche Ltd. (Switzerland) |
| Genedata AG (Switzerland) |
| IntelliCyt® Corporation (USA) |
| Luminex Corporation (USA) |
| PerkinElmer, Inc. (USA) |
| Sigma-Aldrich Corp. (USA) |
| Tecan Group Ltd. (Switzerland) |
| Thermo Fisher Scientific Inc. (USA) |
| 3. MARKET TRENDS & DRIVERS |
| Cell-based Assay: The Widely Used HTS Technology |
| Resolving Technical Limitations: Cornerstone for Future Success of Cell-based HTS |
| HTS Aims to Expand Use Case in Biochemical Applications |
| Label-Free HTS Demonstrates Fastest Growth |
| Lab-on-a-Chip HTS Seeks to Proliferate the Market |
| Bioinformatics HTS Enhanced with Computational Algorithms |
| Positive Prognosis across End-Use Markets to Underpin Revenue Growth |
| Pharmaceutical Industry Leads the Way |
| HTS Deployments Soar in Academia |
| Progressive Advancements in HTS Instruments Accelerate Market Growth |
| Microplate Handling Systems: An Important HTS Instrument Type |
| Liquid Handling Devices: A Necessity in HTS Processes |
| Microscopic Systems Facilitate Seamless Quantitative Analysis |
| Advanced Software Platforms Augment HTS Proficiency |
| Services: An Important Revenue Generating Segment |
| Expansion in Compound Libraries Widens Functional Scope of HTS |
| Compound Libraries Facilitate Simultaneous Functional Genomics & Small Molecule Analysis |
| Laboratory Automation & Miniaturization Spell Opportunities for HTS |
| Miniaturization of Compound Screening Processes Drives Demand for HTS |
| HTS Miniaturization - Technology Developments |
| HTS Robotics Support Miniaturization |
| IVC - A Miniaturized, Powerful HTS Technology |
| HTS Assumes Critical Importance in Target Identification & Validation |
| HTS Gathers Steam in Primary Screening Applications |
| HTS Perceives Bright Future in Stem Cell Research |
| HTS in Kinase Inhibitors Identification |
| HTS in Alzheimer's Disease Drug Discovery |
| HTS for Less Simplified PCR Systems |
| HTFC Eases Metabolic Activity Analysis for Pharmaceutical Drugs |
| Open Access Platforms Widen HTS Audience Base |
| Need for Stringent QA System to Keep Failures at Bay |
| High Throughput Screening (HTS) Vs. High Content Screening (HCS) |
| Rise in Adoption of HCS Technology in HTS Laboratories |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for High Throughput Screening (HTS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Consumables/Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Consumables/Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Consumables/Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Cell-based Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cell-based Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cell-based Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Label-Free Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Label-Free Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Label-Free Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Target Identification & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Target Identification & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Target Identification & Validation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Primary & Secondary Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Primary & Secondary Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Primary & Secondary Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Toxicology Assessment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Toxicology Assessment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Toxicology Assessment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Academic & Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Academic & Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Academic & Government Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Contract Research Organizations (CRO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Contract Research Organizations (CRO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Contract Research Organizations (CRO) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for High Throughput Screening (HTS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| SPAIN |
| Spain Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Spain Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Spain Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Spain Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| RUSSIA |
| Russia Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Russia Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Russia Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Russia Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for High Throughput Screening (HTS) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| AUSTRALIA |
| Australia Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Australia Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Australia Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Australia Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| INDIA |
| India Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| India Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| India Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| India Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| SOUTH KOREA |
| South Korea Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| South Korea Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| South Korea Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| South Korea Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Rest of Asia-Pacific Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Rest of Asia-Pacific Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Rest of Asia-Pacific Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| LATIN AMERICA |
| Latin America Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for High Throughput Screening (HTS) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| ARGENTINA |
| Argentina Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Argentina Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Argentina Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Argentina Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| BRAZIL |
| Brazil Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Brazil Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Brazil Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Brazil Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| MEXICO |
| Mexico Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Mexico Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Mexico Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Mexico Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Rest of Latin America Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Rest of Latin America Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Rest of Latin America Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| MIDDLE EAST |
| Middle East Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for High Throughput Screening (HTS) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| IRAN |
| Iran Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Iran Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Iran Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Iran Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| ISRAEL |
| Israel Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Israel Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Israel Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Israel Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| SAUDI ARABIA |
| Saudi Arabia Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Saudi Arabia Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Saudi Arabia Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Saudi Arabia Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| UNITED ARAB EMIRATES |
| UAE Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| UAE Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| UAE Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| UAE Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF MIDDLE EAST |
| Rest of Middle East Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Rest of Middle East Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Rest of Middle East Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Rest of Middle East Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| AFRICA |
| Africa Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Value Sales for Consumables/Reagents, Instruments and Software & Services for the Years 2012, 2020 & 2027 |
| Africa Current & Future Analysis for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for High Throughput Screening (HTS) by Technology - Cell-based Assay, Label-Free Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for High Throughput Screening (HTS) by Technology - Percentage Breakdown of Value Sales for Cell-based Assay, Label-Free Technology and Other Technologies for the Years 2012, 2020 & 2027 |
| Africa Current & Future Analysis for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for High Throughput Screening (HTS) by Application - Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for High Throughput Screening (HTS) by Application - Percentage Breakdown of Value Sales for Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment and Other Applications for the Years 2012, 2020 & 2027 |
| Africa Current & Future Analysis for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for High Throughput Screening (HTS) by End-Use - Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for High Throughput Screening (HTS) by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, Contract Research Organizations (CRO) and Other End-Uses for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 41 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com